National and Kapodistrian University of Athens
Μελέτη πολυμορφικών θέσεων τροποποιητικών γονιδίων σε ασθενείς με χρόνιες πνευμονοπάθειες
Abstract
dc:descriptionSummary Chronic pulmonary diseases, such as Chronic obstructive pulmonary disease (COPD) and Bronchiectasis are complex diseases influenced by genetic and environmental factors. COPD is characterized by chronic airflow limitation and a range of pathological changes in the lung, some significant extra-pulmonary effects, and important comorbidities, which may contribute to the severity of the disease in individual patients. COPD is a disease state characterized by airflow limitation that is not fully reversible and associated with an abnormal inflammatory response of the lungs to noxious particles or gases. The chronic airflow limitation characteristic of COPD is caused by a mixture of small airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), the relative contributions of which vary from person to person. Bronchiectasis (DB) is characterized by irreversible focal bronchial dilation, usually accompanied by chronic infection and is due to congenital or hereditary conditions. These morphological changes are usually found with chronic suppurative lung disease, which is characterized by productive cough and purulent sputum expectoration. Bronchiectasis may be focal and limited to a single segment or lobe or it may be widespread and affect multiple lobes in one or both lungs. The present is an association study aiming to investigate the genetic contribution of polymorphisms/ mutations in different genes on the pathogenesis of COPD and DB. Additionally we sought to develop an advanced high throughout methodology for SNP/mutation identification, amenable to automation. The patient groups consisted of 117 stable COPD patients and 62 patients with DB both of Greek origin. The control groups consisted of 109 current asymptomatic and ex smokers but without evidence of COPD or other lung disease and a general population control group (n=212). Whole blood samples from the two patient groups and the asymptomatic smokers were obtained from the COPD Outpatient Clinic of the Respiratory Department of the University of Athens at “Sotiria” Hospital. And the general population control group came from the Department of Medical Genetics of the Medical School of the University of Athens. The TNF-a, SERPINA1 and ADRB2 genes were studied. The results have shown that a TNF-a diplotype could be a risk factor for COPD. While no association was discovered between the mutations/ polymorphisms in the SERPINA1 and ADRB2 genes and COPD, we found that the normal homozygous SERPINA1 p.Val213Val genotype was less prevalent in DB patients than in healthy smokers, which suggested that the p.Ala213 variant may play a role in the pathogenesis of DB. We also showed a significant association between the Gly16 ADRB2 polymorphism and the severity of COPD, which was represented by values for FEV1 percent, predicted. Finally, our study contributed to the standardization of the DNA microarray methodology, which can be used for further analysis of polymorphisms/ mutations in other genes.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Παπαθεοδώρου, Αθανάσιος
- Papatheodorou, Athanasios
Subjects
dc:subject × 20- Χρόνια αναπνευστική πνευμονοπάθεια ( ΧΑΠ)
- Βρογχεκτασίες
- Σημειακοί πολυμορφισμοί
- α1 - αντιθρυψίνη
- β2 - αδρενεργικός υποδοχέας
- Παράγοντες νέκρωσης όγκων -α
- Μικροσυστοιχίες DNA
- α1 - antitrypsin
- β2 - adrenergic receptor
- TNF - a
- DNA microarrays
- Chronic obstructive pulmonary disease (COPD)
- Disseminated bronchiectasis
- SNP
- α1 - antitrpsin
- TNF -a
- Ιατρική και Επιστήμες Υγείας
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27452